Telomerase in cancer and aging
The telomere–telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level,...
Gespeichert in:
| Veröffentlicht in: | Critical reviews in oncology/hematology 2002, Vol.41 (1), p.29-40 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 40 |
|---|---|
| container_issue | 1 |
| container_start_page | 29 |
| container_title | Critical reviews in oncology/hematology |
| container_volume | 41 |
| creator | Granger, Meaghan P. Wright, Woodring E. Shay, Jerry W. |
| description | The telomere–telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level, which may either delay or hasten this arrest. As humans age, a particular concern is the accumulation of events that lead to the progression of cancer. Telomerase is a mechanism that most normal cells do not possess, but almost all cancer cells acquire, to overcome their mortality and extend their lifespan. This review aims to provide a comprehensive understanding of the role of telomerase in cancer development, progression, diagnosis, and in the future, treatment. The ultimate goal of telomerase research is to use our understanding to develop anti-telomerase therapies, an almost universal tumor target. |
| doi_str_mv | 10.1016/S1040-8428(01)00188-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71410059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1040842801001883</els_id><sourcerecordid>71410059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-38decbb77aabc0efef870fd4f1fbc84702ec8d7e2e0124808104c0ec1e5a56093</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EolD4BKpsQLAIzCRO7KwQqnhJlVhQ1pbjTCqjPIrdIvH3uG1Ql6xmFufO4zB2gXCLgPndOwKHWPJEXgPeAKCUcXrATlCKIgae42Ho_5ARO_X-EwA4z8UxGyGKIk9SOGGTOTV9S057imwXGd0ZcpHuqkgvbLc4Y0e1bjydD3XMPp4e59OXePb2_Dp9mMUmLXAVp7IiU5ZCaF0aoJpqKaCueI11aSQXkJCRlaCEABMuQYbLAmeQMp3lUKRjdrWbu3T915r8SrXWG2oa3VG_9kogR4BsA2Y70Ljee0e1WjrbavejENRGjNqKUZuvFaDailFpyE2GBeuypWqfGkwE4HIAtDe6qV0wYf2eS4O6JM8Dd7_jKOj4tuSUN5aCtco6MitV9fafU34B5Ph9rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71410059</pqid></control><display><type>article</type><title>Telomerase in cancer and aging</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Granger, Meaghan P. ; Wright, Woodring E. ; Shay, Jerry W.</creator><creatorcontrib>Granger, Meaghan P. ; Wright, Woodring E. ; Shay, Jerry W.</creatorcontrib><description>The telomere–telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level, which may either delay or hasten this arrest. As humans age, a particular concern is the accumulation of events that lead to the progression of cancer. Telomerase is a mechanism that most normal cells do not possess, but almost all cancer cells acquire, to overcome their mortality and extend their lifespan. This review aims to provide a comprehensive understanding of the role of telomerase in cancer development, progression, diagnosis, and in the future, treatment. The ultimate goal of telomerase research is to use our understanding to develop anti-telomerase therapies, an almost universal tumor target.</description><identifier>ISSN: 1040-8428</identifier><identifier>EISSN: 1879-0461</identifier><identifier>DOI: 10.1016/S1040-8428(01)00188-3</identifier><identifier>PMID: 11796230</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Aging - physiology ; Animals ; Biological and medical sciences ; Cancer ; Carcinogenesis, carcinogens and anticarcinogens ; Enzyme Inhibitors - therapeutic use ; General aspects ; Humans ; Immunosenescence ; Medical sciences ; Neoplasms - enzymology ; Neoplasms - genetics ; Neoplasms - pathology ; Neoplasms - therapy ; Prognosis ; Replicative aging ; Senescence ; Telomerase ; Telomerase - physiology ; Telomerase inhibitors ; Telomere ; Telomere - physiology ; Tumors</subject><ispartof>Critical reviews in oncology/hematology, 2002, Vol.41 (1), p.29-40</ispartof><rights>2002 Elsevier Science Ireland Ltd</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-38decbb77aabc0efef870fd4f1fbc84702ec8d7e2e0124808104c0ec1e5a56093</citedby><cites>FETCH-LOGICAL-c391t-38decbb77aabc0efef870fd4f1fbc84702ec8d7e2e0124808104c0ec1e5a56093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S1040-8428(01)00188-3$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,4010,27904,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13446266$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11796230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Granger, Meaghan P.</creatorcontrib><creatorcontrib>Wright, Woodring E.</creatorcontrib><creatorcontrib>Shay, Jerry W.</creatorcontrib><title>Telomerase in cancer and aging</title><title>Critical reviews in oncology/hematology</title><addtitle>Crit Rev Oncol Hematol</addtitle><description>The telomere–telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level, which may either delay or hasten this arrest. As humans age, a particular concern is the accumulation of events that lead to the progression of cancer. Telomerase is a mechanism that most normal cells do not possess, but almost all cancer cells acquire, to overcome their mortality and extend their lifespan. This review aims to provide a comprehensive understanding of the role of telomerase in cancer development, progression, diagnosis, and in the future, treatment. The ultimate goal of telomerase research is to use our understanding to develop anti-telomerase therapies, an almost universal tumor target.</description><subject>Aging - physiology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immunosenescence</subject><subject>Medical sciences</subject><subject>Neoplasms - enzymology</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - therapy</subject><subject>Prognosis</subject><subject>Replicative aging</subject><subject>Senescence</subject><subject>Telomerase</subject><subject>Telomerase - physiology</subject><subject>Telomerase inhibitors</subject><subject>Telomere</subject><subject>Telomere - physiology</subject><subject>Tumors</subject><issn>1040-8428</issn><issn>1879-0461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EolD4BKpsQLAIzCRO7KwQqnhJlVhQ1pbjTCqjPIrdIvH3uG1Ql6xmFufO4zB2gXCLgPndOwKHWPJEXgPeAKCUcXrATlCKIgae42Ho_5ARO_X-EwA4z8UxGyGKIk9SOGGTOTV9S057imwXGd0ZcpHuqkgvbLc4Y0e1bjydD3XMPp4e59OXePb2_Dp9mMUmLXAVp7IiU5ZCaF0aoJpqKaCueI11aSQXkJCRlaCEABMuQYbLAmeQMp3lUKRjdrWbu3T915r8SrXWG2oa3VG_9kogR4BsA2Y70Ljee0e1WjrbavejENRGjNqKUZuvFaDailFpyE2GBeuypWqfGkwE4HIAtDe6qV0wYf2eS4O6JM8Dd7_jKOj4tuSUN5aCtco6MitV9fafU34B5Ph9rg</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Granger, Meaghan P.</creator><creator>Wright, Woodring E.</creator><creator>Shay, Jerry W.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Telomerase in cancer and aging</title><author>Granger, Meaghan P. ; Wright, Woodring E. ; Shay, Jerry W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-38decbb77aabc0efef870fd4f1fbc84702ec8d7e2e0124808104c0ec1e5a56093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aging - physiology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immunosenescence</topic><topic>Medical sciences</topic><topic>Neoplasms - enzymology</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - therapy</topic><topic>Prognosis</topic><topic>Replicative aging</topic><topic>Senescence</topic><topic>Telomerase</topic><topic>Telomerase - physiology</topic><topic>Telomerase inhibitors</topic><topic>Telomere</topic><topic>Telomere - physiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Granger, Meaghan P.</creatorcontrib><creatorcontrib>Wright, Woodring E.</creatorcontrib><creatorcontrib>Shay, Jerry W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical reviews in oncology/hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Granger, Meaghan P.</au><au>Wright, Woodring E.</au><au>Shay, Jerry W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Telomerase in cancer and aging</atitle><jtitle>Critical reviews in oncology/hematology</jtitle><addtitle>Crit Rev Oncol Hematol</addtitle><date>2002</date><risdate>2002</risdate><volume>41</volume><issue>1</issue><spage>29</spage><epage>40</epage><pages>29-40</pages><issn>1040-8428</issn><eissn>1879-0461</eissn><abstract>The telomere–telomerase hypothesis is the science of cellular aging (senescence) and cancer. The ends of chromosomes, telomeres, count the number of divisions a cell can undergo before entering permanent growth arrest. As divisions are being counted, events occur on the cellular and molecular level, which may either delay or hasten this arrest. As humans age, a particular concern is the accumulation of events that lead to the progression of cancer. Telomerase is a mechanism that most normal cells do not possess, but almost all cancer cells acquire, to overcome their mortality and extend their lifespan. This review aims to provide a comprehensive understanding of the role of telomerase in cancer development, progression, diagnosis, and in the future, treatment. The ultimate goal of telomerase research is to use our understanding to develop anti-telomerase therapies, an almost universal tumor target.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11796230</pmid><doi>10.1016/S1040-8428(01)00188-3</doi><tpages>12</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1040-8428 |
| ispartof | Critical reviews in oncology/hematology, 2002, Vol.41 (1), p.29-40 |
| issn | 1040-8428 1879-0461 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71410059 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aging - physiology Animals Biological and medical sciences Cancer Carcinogenesis, carcinogens and anticarcinogens Enzyme Inhibitors - therapeutic use General aspects Humans Immunosenescence Medical sciences Neoplasms - enzymology Neoplasms - genetics Neoplasms - pathology Neoplasms - therapy Prognosis Replicative aging Senescence Telomerase Telomerase - physiology Telomerase inhibitors Telomere Telomere - physiology Tumors |
| title | Telomerase in cancer and aging |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A14%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Telomerase%20in%20cancer%20and%20aging&rft.jtitle=Critical%20reviews%20in%20oncology/hematology&rft.au=Granger,%20Meaghan%20P.&rft.date=2002&rft.volume=41&rft.issue=1&rft.spage=29&rft.epage=40&rft.pages=29-40&rft.issn=1040-8428&rft.eissn=1879-0461&rft_id=info:doi/10.1016/S1040-8428(01)00188-3&rft_dat=%3Cproquest_cross%3E71410059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71410059&rft_id=info:pmid/11796230&rft_els_id=S1040842801001883&rfr_iscdi=true |